Stimulated serotonin release from hyperinnervated terminals subsequent to neonatal dopamine depletion regulates striatal tachykinin, but not enkephalin gene expression

Molecular Brain Research

Volumn 81, Issue 1-2, 2000, Pages 80-91

  Basura, Gregory J ^a   Walker, Paul D ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Cellular and Clinical Neurobiology Program   (United States)

Author keywords

6 Hydroxydopamine; Basal ganglia; p Chloroamphetamine; Parkinson's disease; Preproenkephalin; Preprotachykinin

Indexed keywords

CHLORAMPHETAMINE; DOPAMINE; ENKEPHALIN; MESSENGER RNA; OXIDOPAMINE; PREPROENKEPHALIN; PREPROTACHYKININ; SEROTONIN; TACHYKININ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEAFFERENTATION; DOPAMINE RELEASE; GENE EXPRESSION REGULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN SITU HYBRIDIZATION; MICROSCOPY; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SEROTONINERGIC NERVE; SEROTONINERGIC TRANSMISSION;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMAL; ANIMALS, NEWBORN; CEREBRAL VENTRICLES; CORPUS STRIATUM; DESIPRAMINE; DOPAMINE; ENKEPHALINS; GENE EXPRESSION REGULATION; HYDROXYINDOLEACETIC ACID; INJECTIONS, INTRAVENTRICULAR; OXIDOPAMINE; P-CHLOROAMPHETAMINE; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEROTONIN; SUPPORT, NON-U.S. GOV'T; TACHYKININS; TRANSCRIPTION, GENETIC;

EID: 0034734801     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(00)00153-4     Document Type: Article

References (59)

1. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12:1989;366-375.
2. 125I-LSD autoradiography confirms the preferential localization of caudate-putamen S2 receptors to the caudal (peripallidal) region. Brain Res. 372:1986;130-136.
3. Anderson K.D., Reiner A. The extensive co-occurrence of substance P and dynorphin in striatal projection neurons: an evolutionary conserved feature of basal ganglia organization. J. Comp. Neurol. 295:1990;339-369.
4. Bannon M.J., Elliott P.J., Bunney E.B. Striatal tachykinin biosynthesis: regulation of mRNA and peptide levels by dopamine agonists and antagonists. Mol. Brain Res. 3:1987;31-37.
5. Bannon M.J., Kelland M., Chiodo L.A. Medial forebrain bundle stimulation or D-2 dopamine receptor activation increases preproenkephalin mRNA in rat striatum. J. Neurochem. 52:1989;859-862.
6. Bannon M.J., Brownschidle L.A., Tian Y., Whitty C.J., Poosch M.S., D'sa C., Moody C.A. Neurokinin-3 receptors modulate dopamine cell function and alter the effects of 6-hydroxydopamine. Brain Res. 695:1995;19-34.
7. Baruch P., Artaud F., Godeheu G., Barbeito L., Glowinski J., Cheramy A. Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons. Neuroscience. 25:1988;889-898.
8. Basura G.J., Walker P.D. Differential sensitivity of tachykinin vs. enkephalin gene expression in the posterior striatum in response to acute p-chloroamphetamine treatment during postnatal development. Dev. Brain Res. 112:1999;155-157.
9. Basura G.J., Walker P.D. Serotonin 2A receptor mRNA levels in the neonatal dopamine-depleted rat striatum remain upregulated following suppression of serotonin hyperinnervation. Dev. Brain Res. 116:1999;111-117.
10. Basura G.J., Walker P.D. Suppression of serotonin hyperinnervation does not alter the dysregulatory influences of dopamine depletion on striatal neuropeptide gene expression in rodent neonates. Neurosci. Lett. 274:1999;9-12.
11. Basura G.J., Walker P.D. Serotonin 2A and 2C receptor biosynthesis in the rodent striatum during postnatal development: mRNA expression and functional linkage to neuropeptide gene regulation. Synapse. 2000;. in press.
12. Basura G.J., Walker P.D. Evidence for a strengthening of serotonin 2A receptor-mediated signal transduction within tachykinin neurons of the rostral striatum following neonatal dopamine depletion. J. Neurosci. 2000;. submitted.
13. Berger T.W., Kaul S., Stricker E.M., Zigmond M.J. Hyperinnervation of the striatum by dorsal raphe afferents after dopamine-depleting brain lesions in neonatal rats. Brain Res. 336:1985;354-358.
14. Castaneda E., Whishaw I.Q., Lerner L., Robinson T.E. Dopamine depletion in neonatal rats: effects on behavior and striatal dopamine release assessed by intracerebral microdialysis during adulthood. Brain Res. 508:1990;30-39.
15. +2-dependent 5-HT and dopamine release by (+)-amphetamine, 3,4,-methylendioxy-methamphetamine, p-chloroamphetamine and (+)-fenfluramine. Br. J. Pharmacol. 121:1997;1735-1743.
16. Frohna P.A., Neal-Beliveau B.S., Joyce J.N. Neonatal 6-hydroxydopamine lesions lead to opposing changes in the levels of dopamine receptors and their messenger RNAs. Neuroscience. 68:1995;505-518.
17. Fuller R.W., Snoddy H.D. Long-term effects of 4-chloroamphetamine on brain 5-hydroxyindole metabolism in rats. Neuropharmacology. 13:1974;85-90.
18. 1 receptor development depends on endogenous dopamine. Dev. Brain Res. 56:1990;137-140.
19. Gerfen C.R., Young W.S. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460:1988;161-167.
20. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
21. Gerfen C.R., McGinty J.F., Young W.S. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: In situ hybridization histochemical analysis. J. Neurosci. 11:1991;1016-1031.
22. Gresch P.J., Walker P.D. Acute p-chloroamphetamine increases striatal preprotachykinin mRNA: role of the serotonin 2A/2C receptor. Mol. Brain Res. 67:1999;190-193.
23. Gresch P.J., Walker P.D. Serotonin-2 receptor stimulation normalizes striatal preprotachykinin mRNA in an animal model of Parkinson's disease. Neuroscience. 93:1999;831-841.
24. Hagan J., Middlemiss D., Sharp P., Poste G. Parkinson's disease: prospects for improved drug therapy. Trends Pharmacol. Sci. 18:1997;156-163.
25. Harvey J., McMaster S., Yunger L. p-Chloroamphetamine: selective neurotoxic action in brain. Science. 187:1975;841-843.
26. Hobson D., Pourcher E., Martin W. Ropinirole and pramipexole, the new agonists. Can. J. Neurol. Sci. 26:(Suppl. 2):1999;S27-S33.
27. Jaber M., Cador M., Dumartin B., Normand E., Stinus L., Bloch B. Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons. Neuroscience. 65:1995;1041-1050.
28. Jackson D., Abercrombie E.D. In vivo neurochemical evaluation of striatal serotonergic hyperinnervation in rats depleted of dopamine at infancy. J. Neurochem. 58:1992;890-897.
29. Kita H., Kitai S.T. Glutamate decarboxylase immunoreactive neurons in rat neostriatum: their morphological types and populations. Brain Res. 447:1988;346-352.
30. Krasnova I.N., Bychkov E.R., Lioudyno V.I., Zubareva O.E., Dambinova S.A. Intracerebroventricular administration of substance P increases dopamine content in the brain of 6-hydroxydopamine-lesioned rats. Neuroscience. 95:2000;113-117.
31. Krause J.E., Chirgwin J.M., Carter M.S., Xu Z.S., Hershey A.D. Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc. Natl. Acad. Sci. USA. 84:1987;881-885.
32. 2A receptor and its mRNA in a subpopulation of rat striatal neurons. J. Neurosci. 16:1996;3727-3736.
33. 2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. Comp. Neurol. 355:1995;418-426.
34. Leslie R.A., Moorman J.M., Coulson A., Grahame-Smith D.G. Serotonin 2/1C receptor activation causes a localized expression of the immediate-early gene c-fos in rat brain: evidence for involvement of dorsal raphe nucleus projection fibers. Neuroscience. 53:1993;457-463.
35. Lowry O., Rosebrough M., Farr A., Randall R. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
36. Luthman J., Brodin E., Sundstrom E., Wiehager B. Studies on brain monoamine and neuropeptide systems after neonatal intracerebroventricular 6-hydroxydopamine treatment. Int. J. Dev. Neurosci. 8:1990;549-560.
37. Molina-Holgado E., Dewar K.M., Descarries L., Reader T.A. Altered dopamine and serotonin metabolism in the dopamine-denervated and serotonin-hyperinnervated neostriatum of adult rat after neonatal 6-hydroxydopamine. J. Pharmacol. Exp. Ther. 270:1994;713-721.
38. Moorman J.M., Leslie R.A. p-chloroamphetamine induces c-fos in rat brain: a study of serotonin 2A/2C receptor function. Neuroscience. 72:1996;129-139.
39. Neal-Beliveau B.S., Joyce J.N. D1 and D2 dopamine receptors do not up-regulate in response to neonatal intrastriatal 6-hydroxydopamine lesions. Neurosci. Lett. 160:1993;77-80.
40. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, New York.
41. Pickel V.M., Johnson E., Carson M., Chan J. Ultrastructure of spared dopamine terminals in caudate-putamen nuclei of adult rats neonatally treated with intranigral 6-hydroxydopamine. Dev. Brain Res. 70:1992;75-86.
42. Piercey M. Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease. Clin. Neuropharmacol. 21:1998;141-151.
43. Rabey J. Nissipeanu P, Inzelberg R, Korczyn A, Beneficial effect of cabergoline, a new long-lasting D2 agonist in the treatment of Parkinson's disease. Clin. Neuropharmacol. 17:1994;286-293.
44. Radja F., Descarries L., Dewar K., Reader T. Serotonin 5-HT1 and 5-HT2 receptors in adult rat brain after neonatal destruction of nigrostriatal dopamine neurons: a quantitative autoradiographic study. Brain Res. 606:1993;273-285.
45. Sanders-Bush E., Steranka L.R. Immediate and long-term effects of p-chloroamphetamine on brain amines. Ann. NY Acad. Sci. 305:1978;208-221.
46. Sharp T., Zetterstrom T., Christmanson L., Ungerstedt U. p-chloroamphetamine releases both serotonin and dopamine into rat brain dialysates in vivo. Neurosci. Lett. 72:1986;320-324.
47. Sivam S.P. Postnatal deficiency of dopamine but not serotonin affects the development of striatal enkephalin and tachykinin systems. Soc. Neurosci. Abstr. 21:1995;862.
48. Sivam S.P., Breese G.R., Krause J.E., Napier T.C., Mueller R.A., Hong J.-S. Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression. J. Neurochem. 49:1987;1623-1633.
49. Snyder A.M., Zigmond M.J., Lund R. Sprouting of serotonergic afferents into striatum after dopamine-depleting lesions in infant rats: a retrograde transport and immunocytochemical study. J. Comp. Neuol. 245:1986;274-281.
50. Snyder-Keller A.M. Striatal c-fos induction by drugs and stress in neonatally dopamine depleted rats given nigral transplants: importance of NMDA activation and relevance to sensitization phenomena. Exp. Neurol. 113:1991;155-165.
51. Soghomonian J.J., Laprade N., Sandstrom M., Bruno J.P. C-fos gene expression is induced in a subpopulation of striatal neurons following a single administration of a dopamine D1-receptor agonist in adult lesioned with 6-OHDA as neonates. Mol. Brain Res. 57:1998;155-160.
52. Stachowiak M.K., Bruno J.P., Snyder A.M., Stricker E.M., Zigmond M.J. Apparent sprouting of striatal serotonergic terminals after dopamine-depleting lesions in neonatal rats. Brain Res. 291:1984;164-167.
53. Tang F.I., Chiu T.H., Wang Y. Electrochemical studies of the effects of substance P on dopamine terminals in the rat striatum. Exp. Neurol. 152:1998;41-49.
54. Ternaux J.P., Hery F., Bourgoin S., Adrien J., Glowinski J., Hamon M. The topographical distribution of serotonergic terminals in the neostriatum of the rat and caudate nucleus of the cat. Brain Res. 121:1977;311-326.
55. Walker P.D., Capodilupo J.J., Wolf W.A., Carlock L.R. Preprotachykinin and preproenkephalin mRNA expression within striatal subregions in response to altered serotonin transmission. Brain Res. 732:1996;25-35.
56. Walker P.D., Riley L.A., Hart R.P., Jonakait G.M. Serotonin regulation of tachykinin biosynthesis in the rat neostriatum. Brain Res. 546:1991;33-39.
57. Wang J.Q., McGinty J.F. Acute methamphetamine-induced zif/268, preprodynorphin, and preproenkephalin mRNA expression in rat striatum depends on activation of NMDA and Kainate/AMPA receptors. Brain Res. Bull. 39:1996;349-357.
58. Ward R.W., Dorsa D.M. Colocalization of serotonin receptor subtypes 5-HT2A, 5-HT2C, and 5-HT6 with neuropeptide mRNAs in the rat forebrain. J. Comp. Neurol. 370:1996;405-414.
59. Yoshikawa K., Williams C., Sabol S.L. Rat brain preprotachykinin mRNA. J. Biol. Chem. 259:1984;14301-14308.